Skip to content

CLINICAL STUDY OF RADIOFREQUENCY COMBINED WITH ANHYDROUS ETHANOL IN THE TREATMENT OF INTRACTABLE POST-HERPETIC NEURALGIA

Thoracic nerve lesion in the treatment of postherpetic neuralgia: double target is better than single target method

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032631
Enrollment
Unknown
Registered
2020-05-04
Start date
2017-01-01
Completion date
Unknown
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postherpetic neuralgia.

Interventions

radio frequency-alcohol group: radiofrequency thermocoagulation at the nerve root, anhydrous ethanol at the nerve trunk,
radio frequency group:radiofrequency thermocoagulation at the nerve root

Sponsors

The fourth affiliated hospital of Harbin medical university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The pain lasted for more than 3 months after the chest and back rash healed, and the VAS score was more than 7 before treatment; 2. The effect of conservative treatment such as oral medicine and nerve block was not good; 3. The lesion was located in T2-12 nerve control area; 4. MRI examination of thoracic vertebrae showed that the subjects agreed to thoracic nerve destruction treatment.

Exclusion criteria

Exclusion criteria: 1. complicated with severe cardiac, pulmonary and renal insufficiency; 2. complicated with coagulation dysfunction; 3. combined with mental disorders and mental disorders with poor cooperation; 4. infected patients at the puncture site.

Design outcomes

Primary

MeasureTime frame
pain score;

Secondary

MeasureTime frame
Pain relief rate;Overall efficiency;

Countries

China

Contacts

Public ContactZhong Huacheng

The Fourth Affiliated Hospital of Harbin Medical University

zhouhuacheng@126.com+86 13936184872

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026